Abstract
Purpose
In this study, we synthesized hyaluronic acid-conjugated gadolinium (HA-diethylene triamine pentaacetic acid (DTPA)-Gd) and evaluated as hepatocyte-specific magnetic resonance imaging (MRI) contrast agent for the diagnosis of hepatic metastasis.
Procedures
We conducted Fourier transform (FT)-IR analysis to determine the conjugation of HA and DTPA and performed cell viability assays using NIH3T3 and FL83B cell lines. We also conducted T1-weighted MRI of HA-DTPA-Gd and gadoxetic acid to compare the paramagnetic properties of both.
Results
HA-DTPA-Gd had a higher efficiency in liver MRI compared with the commercially available liver-specific contrast agent (p < 0.001). HA-DTPA-Gd, which possessed a higher T1 relaxivity, showed excellent capability for the diagnosis of hepatic metastasis through an in vivo MRI study in comparison with gadoxetic acid (p < 0.001).
Conclusion
Based on this study, we believe that HA-DTPA-Gd has promising potential for use as a contrast agent for liver MRI of hepatic metastases.
Similar content being viewed by others
References
Jemal A, Bray F, Center MM et al (2011) Global cancer statistics. Ca Cancer J Clin 61:69–90
Bipat S, Leeuwen MS, Comans EF et al (2005) Colorectal liver metastases: CT, MR imaging, and PET for diagnosis—meta-analysis. Radiology 237:123–131
Niekel MC, Bipat S, Stoker J (2010) Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Radiology 257:674–684
Lafaro KJ, Roumanis P, Demirjian AN et al (2013) Gd-EOB-DTPA-enhanced MRI for detection of liver metastases from colorectal cancer: a surgeon’s perspective! Int J Hepatol 2013:7
Caravan P, Ellison JJ, McMurry TJ, Lauffer RB (1999) Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 99:2293–2352
Semelka RC, Helmberger TK (2001) Contrast agents for MR imaging of the liver. Radiology 218:27–38
Bellin MF, Vasile M, Morel-Precetti S (2003) Currently used non-specific extracellular MR contrast media. Eur Radiol 13:2688–2698
Huppertz A, Balzer T, Blakeborough A et al (2004) Improved detection of focal liver lesions at MR imaging: multicenter comparison of gadoxetic acid-enhanced MR images with intraoperative findings. Radiology 230:266–275
Seale MK, Catalano OA, Saini S et al (2009) Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 29:1725–1748
Shimada K, Isoda H, Hirokawa Y et al (2010) Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases. Eur Radiol 20:2690–2698
Reimer P, Schneider G, Schima W (2004) Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol 14:559–578
Dohr O, Hofmeister R, Treher M, Schweinfurth H (2007) Preclinical safety evaluation of Gd-EOB-DTPA (Primovist). Invest Radiol 42:830–841
Weinmann HJ, Schuhmann-Giampieri G, Schmitt-Willich H et al (1991) A new lipophilic gadolinium chelate as a tissue-specific contrast medium for MRI. Magn Reson Med 22:233–237
Hammerstingl R, Huppertz A, Breuer J, European EOB study group (2008) Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions. Eur Radiol 18:457–467
Kim KS, Hur W, Park SJ et al (2010) Bioimaging for targeted delivery of hyaluronic acid derivatives to the livers in cirrhotic mice using quantum dots. ACS Nano 4:3005–3014
Zhou B, Weigel JA, Fauss L, Weigel PH (2000) Identification of the hyaluronan receptor for endocytosis (HARE). J Biol Chem 275:37733–37741
Satoh T, Ichida T, Matsuda Y et al (2000) Interaction between hyaluronan and CD44 in the development of dimethylnitrosamine-induced liver cirrhosis. J Gastroenterol Hepatol 15:402–411
Cruickshank SM, Southgate J, Wyatt JI et al (1999) Expression of CD44 on bile ducts in primary sclerosing cholangitis and primary biliary cirrhosis. J Clin Pathol 52:730–734
Fraser JR, Laurent TC, Pertoft H, Baxter E (1981) Plasma clearance, tissue distribution and metabolism of hyaluronic acid injected intravenously in the rabbit. Biochem J 200:415–424
Ashwinkumar N, Maya S, Jayakumar R (2014) Redox-responsive cystamine conjugated chitin-hyaluronic acid composite nanogels. RSC Adv 4:49547–49555
Saravanakumar G, Deepagan VG, Jayakumar R, Park JH (2014) Hyaluronic acid-based conjugates for tumor-targeted drug delivery and imaging. J Biomed Nanotechnol 10:17–31
Cho HJ, Yoon HY, Koo H (2012) Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis. J Control Release 162:111–118
Li J, He Y, Sun W et al (2014) Hyaluronic acid-modified hydrothermally synthesized iron oxide nanoparticles for targeted tumor MR imaging. Biomaterials 35:3666–3677
Park JH, Cho HJ, Yoon HY et al (2014) Hyaluronic acid derivative-coated nanohybrid liposomes for cancer imaging and drug delivery. J Control Release 174:98–108
Yim H, Yang SG, Jeon YS et al (2011) The performance of gadolinium diethylene triamine pentaacetate-pullulan hepatocyte-specific T1 contrast agent for MRI. Biomaterials 32:5187–5194
Buffa R, Betak J, Kettou S et al (2011) A novel DTPA cross-linking of hyaluronic acid metal complexation thereof. Carbohydr Res 346:1909–1915
Heijstek MW, Kranenburg O, Rinkes B (2005) Mouse models of colorectal cancer and liver metastases. Dig Surg 22:16–25
Pierre VC, Botta M, Raymond KN (2005) Dendrimeric gadolinium chelate with fast water exchange and high relaxivity at high magnetic field strength. J Am Chem Soc 127:504–505
Caravan P, Astashkin AV, Raitsimring AM (2003) The gadolinium(III)-water hydrogen distance in MRI contrast agents. Inorg Chem 42:3972–3974
Caravan P (2006) Strategies for increasing the sensitivity of gadolinium based MRI contrast agents. Chem Soc Rev 35:512–523
Werner EJ, Datta A, Jocher CJ, Raymond KN (2008) High-relaxivity MRI contrast agents: where coordination chemistry meets medical imaging. Angew Chem 47:8568–8580
Isaji S, Kawarada Y (2002) Changes in serum hyaluronic acid levels and expression of CD44 and CD44 mRNA in hepatic sinusoidal endothelial cells after major hepatectomy in cirrhotic rats. World J Surg 26:694–699
Acknowledgments
This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2011–0023317)
Conflict of Interest
The authors declare that they have no conflict of interest.
Author Contributions
The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.
Ethical Approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Moon, M., Thomas, R.G., Heo, Su. et al. A Hyaluronic Acid-Conjugated Gadolinium Hepatocyte-Specific T1 Contrast Agent for Liver Magnetic Resonance Imaging. Mol Imaging Biol 17, 497–503 (2015). https://doi.org/10.1007/s11307-014-0819-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-014-0819-z